- Home
- MBIO vs ABTS Comparison
MBIO vs ABTS Comparison
Compare MBIO & ABTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBIO | ABTS |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 3.8M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MBIO | ABTS |
|---|---|---|
| Price | $0.42 | $0.35 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 32.2K | ★ 163.8K |
| Earning Date | 11-24-2026 | 10-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $405.45 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.35 | $0.31 |
| 52 Week High | $1.44 | $6.90 |
Technical Indicators
Market Signals| Indicator | MBIO | ABTS |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 17.22 |
| Support Level | $0.35 | $0.31 |
| Resistance Level | $0.43 | $1.56 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | 0.01 | -0.05 |
| Stochastic Oscillator | 47.80 | 4.36 |
Price Performance
Historical ComparisonAbout MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About ABTS Abits Group Inc
Abits Group Inc is a bitcoin mining company. The Company operates self-owned and hosted bitcoin mining facilities in Tennessee, United States.